SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): April 7, 2004 (April 7, 2004)
ENDO PHARMACEUTICALS HOLDINGS INC.
| DELAWARE | 001-15989 | 13-4022871 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
||
| 100 Painters Drive Chadds Ford, Pennsylvania |
19317 | |
| (Address of principal executive offices) | (Zip Code) | |
(610) 558-9800
N/A
| Item 7. Financial Statements and Exhibits. | ||||||||
| Item 9. Regulation FD Disclosure. | ||||||||
| SIGNATURES | ||||||||
| INDEX TO EXHIBITS | ||||||||
| EX-99.1: SLIDE PRESENTATION | ||||||||
Item 7. Financial Statements and Exhibits.
| (a) | Financial Statements of Business Acquired. |
Not applicable.
| (b) | Pro Forma Financial Information. |
Not applicable.
| (c) | Exhibits. |
| Exhibit Number |
Description |
|
99.1
|
Slide Presentation of Endo Pharmaceuticals Holdings Inc. dated April 7, 2004 |
Item 9. Regulation FD Disclosure.
On April 7, 2004, the Registrant intends to make a slide presentation at the The Buckingham Research Group Inc. Specialty Pharmaceuticals Conference in Boston, Massachusetts, a copy of which presentation is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| ENDO PHARMACEUTICALS HOLDINGS INC. | ||||
| (Registrant) | ||||
| By: | /s/ CAROL A. AMMON | |||
| Name: Carol A. Ammon Title: Chairman & Chief Executive Officer |
||||
Dated: April 7, 2004 |
||||